Assessing the Effectiveness of Add-On Therapy of Palmitoylethanolamide to Standard Therapy in Diabetic Peripheral Neuropathy
Background: Diabetic Peripheral Neuropathy (DPN) is a common yet challenging complication of diabetes, particularly in managing neuropathic pain. Palmitoylethanolamide (PEA), a naturally occurring nutraceutical from the ALIAmides group, has demonstrated potential for pain modulation, inflammation r...
Saved in:
Main Authors: | Velusamy Sivakumar, Thangavelu Saravanan, V.K. Damini |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center for Rational Use of Drugs (RCRUD)
2024-12-01
|
Series: | Journal of Pharmaceutical Care |
Subjects: | |
Online Access: | https://jpc.tums.ac.ir/index.php/jpc/article/view/763 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review
by: Giustino Varrassi, et al.
Published: (2024-12-01) -
Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
by: Yutaka Torii, et al.
Published: (2025-02-01) -
Depression among outpatients with diabetic peripheral neuropathy: prevalence and associated factors
by: Besher Gharaibeh, et al.
Published: (2025-12-01) -
Effects of acupuncture-related intervention on chemotherapy-induced peripheral neuropathy and quality of life: An umbrella review
by: Mei-Ling Yeh, et al.
Published: (2025-05-01) -
A randomized controlled trial: Effects of compression therapy combined with exercise on chemotherapy-induced peripheral neuropathy in patients with breast cancer
by: Yu Xiaoqian, et al.
Published: (2024-01-01)